The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease.
about
Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis.Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compared to branded ciclosporin in Cremophor ® ELColon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus.Ulcerative colitis: prevention of relapse.Role in calcineurin inhibitors for inflammatory bowel disease in the biologics era: when and how to use.A Comparison of Short- and Long-Term Therapeutic Outcomes of Infliximab- versus Tacrolimus-Based Strategies for Steroid-Refractory Ulcerative Colitis.Efficacy and Safety of Tacrolimus Therapy for Active Ulcerative Colitis; A Systematic Review and Meta-analysis.The safety of non-biological treatments in Ulcerative Colitis.Recent trends and future directions for the medical treatment of ulcerative colitis.Pharmacologic therapies for severe steroid refractory hospitalized ulcerative colitis: A network meta-analysis.
P2860
Q34213109-5E38CDE0-3D7D-44E3-A654-5639D4E8459FQ34313613-510B2201-7962-4457-BC6A-AF8593C1DBD8Q36830507-E759F131-4176-4198-BB09-D4FFD49C2028Q38103628-D1E3D421-2244-40B0-850A-3F871B8981F2Q38230163-3FDDB639-F255-4C5A-A160-DCC1A866B8DAQ38287132-D91C0E20-E167-491C-9AAE-B9F9D349C012Q38662186-1C858FDF-4DE2-4C4F-A505-20F03E9D3A02Q38728164-630D2A87-314D-4C2D-AFD0-33101CA43DD5Q38815035-1EB6C74E-5AC0-4AC5-8299-5F33884232C6Q48161573-B514BA8D-EF0B-409D-ADA9-36A94A00C102
P2860
The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease.
@en
The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease.
@nl
type
label
The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease.
@en
The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease.
@nl
prefLabel
The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease.
@en
The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease.
@nl
P2093
P2860
P1476
The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease.
@en
P2093
Makoto Naganuma
Mamoru Watanabe
Toshimitsu Fujii
P2860
P304
P356
10.1007/S00535-010-0352-Z
P577
2010-12-04T00:00:00Z